The Australian Diabetes Society Council established the Clinical Standards/Guidelines Advisory Committee (CAC) in 2021 and is a key strategic pillar on the operations and functions of the organisation. Members are appointed by an expression of interest from the membership on an initial two-year term.
Chair: Prof Jonathan Shaw
Members: A/Prof Stephen Stranks, Prof Jane Holmes-Walker, Prof Jerry Greenfield, Prof Sophia Zoungas, Dr Gary Deed, Prof Michael Horowitz,
Prof Elif Ekinci, Dr Diana Mackay, Dr Shoshana Sztal-Mazer, Dr Sof Andrikopoulos
(a) The Australian Diabetes Society (Society) Clinical Guidelines/Standards Advisory Committee (CAC or Committee) is a subcommittee of the Society, and provides advice to the Society’s Council (Council).
(b) The CAC aims to promote and support high quality clinical guidelines and standards for the prevention, diagnosis and management of diabetes mellitus and related conditions.
(c) CAC’s functions are:
(i) to provide advice to the Council on clinical guidelines/standards priorities;
(ii) to identify, oversee and prioritise the review of existing, and initiate new, position statements, guidelines and
treatment/management algorithms for the Society;
(iii) to review and provide input and guidance into NADC and DFA standards;
(iv) to respond to requests to review and provide input/comments into standards, guidelines and position statements developed by other external groups, including DA, ADEA, ADIPS, APEG, RACP, RACGP, CSANZ, ANZSN;
(v) such other functions as are reasonably determined by the Council.
(d) Office bearers and members of the Committee or any subcommittee of the Committee, must obtain express written permission from the Council or President of the Council before purporting to act or communicate on behalf of the Society or the Council.